{"id":"NCT04697381","sponsor":"Pfizer","briefTitle":"Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS","officialTitle":"A PHASE 3 MULTICENTER, OPEN LABEL, MULTI COHORT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SOMATROPIN IN JAPANESE PARTICIPANTS WITH PRADER-WILLI SYNDROME (PWS)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-02-09","primaryCompletion":"2022-12-06","completion":"2024-04-15","firstPosted":"2021-01-06","resultsPosted":"2024-06-05","lastUpdate":"2024-06-05"},"enrollment":33,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Prader-Willi Syndrome"],"interventions":[{"type":"BIOLOGICAL","name":"somatropin - GH naïve pediatric cohort","otherNames":[]},{"type":"BIOLOGICAL","name":"somatropin - GH treated cohort","otherNames":[]},{"type":"BIOLOGICAL","name":"somatropin - adult cohort","otherNames":[]}],"arms":[{"label":"somatropin - GH naïve pediatric cohort","type":"EXPERIMENTAL"},{"label":"somatropin - GH treated pediatric cohort","type":"EXPERIMENTAL"},{"label":"somatropin - adult cohort","type":"EXPERIMENTAL"}],"summary":"This is a multicenter, open label, multi cohort study to evaluate the efficacy and safety of somatropin in a cohort of Japanese participants with PWS.","primaryOutcome":{"measure":"Change From Baseline to Month 12 in Lean Body Mass Measured by Dual-Energy X-ray Absorptiometry (DEXA): Adult Cohort","timeFrame":"Baseline, Month 12","effectByArm":[{"arm":"Adult Cohort","deltaMin":3.09,"sd":null}],"pValues":[]},"eligibility":{"minAge":"0 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":5,"countries":["Japan"]},"refs":{"pmids":["40436776"],"seeAlso":["https://pmiform.com/clinical-trial-info-request?StudyID=A6281323"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":6},"commonTop":["Fall","Pyrexia","Contusion","Glycosylated haemoglobin increased","Constipation"]}}